FR2309213B1 - - Google Patents

Info

Publication number
FR2309213B1
FR2309213B1 FR7612472A FR7612472A FR2309213B1 FR 2309213 B1 FR2309213 B1 FR 2309213B1 FR 7612472 A FR7612472 A FR 7612472A FR 7612472 A FR7612472 A FR 7612472A FR 2309213 B1 FR2309213 B1 FR 2309213B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7612472A
Other versions
FR2309213A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntex USA LLC
Original Assignee
Syntex USA LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex USA LLC filed Critical Syntex USA LLC
Publication of FR2309213A1 publication Critical patent/FR2309213A1/fr
Application granted granted Critical
Publication of FR2309213B1 publication Critical patent/FR2309213B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1641Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7612472A 1975-04-28 1976-04-27 Pastille d'implantation a noyau inerte Granted FR2309213A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57203175A 1975-04-28 1975-04-28

Publications (2)

Publication Number Publication Date
FR2309213A1 FR2309213A1 (fr) 1976-11-26
FR2309213B1 true FR2309213B1 (fr) 1979-05-04

Family

ID=24286057

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7612472A Granted FR2309213A1 (fr) 1975-04-28 1976-04-27 Pastille d'implantation a noyau inerte

Country Status (11)

Country Link
US (1) US4096239A (fr)
JP (1) JPS51133411A (fr)
AU (1) AU502767B2 (fr)
BE (1) BE841164A (fr)
CA (1) CA1076480A (fr)
DE (1) DE2618130A1 (fr)
FR (1) FR2309213A1 (fr)
GB (1) GB1522735A (fr)
NL (1) NL7604460A (fr)
NZ (1) NZ180684A (fr)
ZA (1) ZA762543B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4180560A (en) * 1976-10-26 1979-12-25 Syntex Corporation Inert core implant pellet
US4191741A (en) * 1978-09-22 1980-03-04 Eli Lilly And Company Removable drug implant
US4292965A (en) * 1978-12-29 1981-10-06 The Population Council, Inc. Intravaginal ring
US4326524A (en) * 1980-09-30 1982-04-27 Minnesota Mining And Manufacturing Company Solid dose ballistic projectile
US4379454A (en) * 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
US4460372A (en) * 1981-02-17 1984-07-17 Alza Corporation Percutaneous absorption enhancer dispenser for use in coadministering drug and percutaneous absorption enhancer
US4754745A (en) * 1984-11-21 1988-07-05 Horowitz Bruce S Conformable sheet material for use in brachytherapy
US4697575A (en) * 1984-11-21 1987-10-06 Henry Ford Hospital Delivery system for interstitial radiation therapy including substantially non-deflecting elongated member
US4797275A (en) * 1985-09-26 1989-01-10 Eli Lilly And Company Nicarbazin feed premix
US4757062A (en) * 1985-11-01 1988-07-12 E. I. Du Pont De Nemours And Company Substituted benzoate ester prodrugs of estrogens
US4763642A (en) * 1986-04-07 1988-08-16 Horowitz Bruce S Intracavitational brachytherapy
US4917685A (en) * 1986-05-16 1990-04-17 International Minerals & Chem. Corp. Delivery device for the administration of stabilized growth promoting hormones
CA1257199A (fr) * 1986-05-20 1989-07-11 Paul Y. Wang Preparation contenant une substance macromoleculaire ayant des proprietes biologiques liberee pendant plusieurs mois in vivo
US4758435A (en) * 1986-08-11 1988-07-19 American Cyanamid Company Estradiol implant composition and method for preparation
US4906475A (en) * 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
US5208032A (en) * 1988-07-15 1993-05-04 Rutgers, The State University Of New Jersey Increasing the growth of turkeys using implant of 19-nortestosterone
US5108755A (en) * 1989-04-27 1992-04-28 Sri International Biodegradable composites for internal medical use
ZA924811B (en) * 1991-06-28 1993-12-29 Endorecherche Inc Controlled release systems and low dose androgens
HU222501B1 (hu) * 1991-06-28 2003-07-28 Endorecherche Inc. MPA-t vagy MGA-t tartalmazó nyújtott hatóanyag-felszabadulású gyógyászati készítmény és eljárás előállítására
US5633000A (en) * 1994-06-23 1997-05-27 Axxia Technologies Subcutaneous implant
US20030157187A1 (en) * 1996-12-02 2003-08-21 Angiotech Pharmaceuticals, Inc. Compositions and methods for treating or preventing inflammatory diseases
US6022554A (en) * 1997-12-15 2000-02-08 American Home Products Corporation Polymeric microporous film coated subcutaneous implant
ATE289213T1 (de) 1997-12-29 2005-03-15 Alza Corp Kit zum implantieren eines implantats
US6248127B1 (en) * 1998-08-21 2001-06-19 Medtronic Ave, Inc. Thromboresistant coated medical device
MXPA06001401A (es) * 2003-08-06 2006-05-19 Nirmal Mulye Composicion farmaceutica que contiene farmaco soluble en agua.
US20060034943A1 (en) * 2003-10-31 2006-02-16 Technology Innovations Llc Process for treating a biological organism
KR101914119B1 (ko) * 2010-03-16 2018-11-02 타이탄 파머슈티컬즈 인코퍼레이티드 약물 전달용 이종 이식가능 장치
WO2023230619A1 (fr) * 2022-05-26 2023-11-30 Insigna Inc. Prévention de l'œstrus chez la truie et les ruminants
US11938140B2 (en) 2022-05-26 2024-03-26 Insigna Inc. Non-surgical prevention of boar taint and aggressive behavior

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2921883A (en) * 1957-05-03 1960-01-19 Smith Kline French Lab Novel coating material for medicaments
FR1534254A (fr) * 1966-08-16 1968-07-26 Phytogen Products Procédé pour bloquer et favoriser l'oestrus et produit de blocage
US3499445A (en) * 1966-08-16 1970-03-10 Phytogen Prod Inc Animal husbandry
US3443561A (en) * 1966-08-23 1969-05-13 Phytogen Prod Inc Subcutaneous implant device

Also Published As

Publication number Publication date
DE2618130A1 (de) 1976-11-18
ZA762543B (en) 1977-12-28
JPS51133411A (en) 1976-11-19
GB1522735A (en) 1978-08-31
NZ180684A (en) 1978-03-06
AU502767B2 (en) 1979-08-09
CA1076480A (fr) 1980-04-29
US4096239A (en) 1978-06-20
NL7604460A (nl) 1976-11-01
BE841164A (fr) 1976-10-27
AU1335676A (en) 1977-11-03
FR2309213A1 (fr) 1976-11-26

Similar Documents

Publication Publication Date Title
FR2299872B1 (fr)
CH598745A5 (fr)
BG22316A1 (fr)
BG22152A1 (fr)
BG22264A1 (fr)
BG22273A1 (fr)
CH599232A5 (fr)
BG22696A1 (fr)
BG22878A1 (fr)
BG23118A1 (fr)
CH1355175A4 (fr)
CH599922A5 (fr)
CH584348A5 (fr)
CH590481A5 (fr)
CH590551A5 (fr)
CH592752A5 (fr)
CH593137A5 (fr)
CH593320A5 (fr)
CH593567A5 (fr)
CH594602A5 (fr)
CH594743A5 (fr)
CH594971A5 (fr)
CH595521A5 (fr)
CH595627A5 (fr)
CH596055A5 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse